Acquired resistance to bispecific antibodies by genetic or epigenetic inactivation of the target in multiple myeloma
Jennifer Derrien(Inserm), Éric Letouzé(Centre National de la Recherche Scientifique)
Cited by 0
Related Papers
Cyclin A2/E1 activation defines a hepatocellular carcinoma subclass with a rearrangement signature of replication stress
|Nature Communications|2018|150